Description
SMS Pharmaceuticals Ltd lists 50 lakh equity shares issued to promoters on preferential basis pursuant to warrant conversion, with lock-in until October 2027.
Summary
SMS Pharmaceuticals Ltd (Scrip Code: 532815) has listed 50,00,000 new equity shares on BSE, effective November 7, 2025. These shares were issued to promoters on a preferential basis pursuant to conversion of warrants, with an allotment date of September 10, 2025. The shares carry a lock-in period until October 30, 2027.
Key Points
- 50,00,000 equity shares of Re. 1/- each listed on BSE
- Issued at a premium of Rs. 126/- (total issue price: Rs. 127/-)
- Allotted to promoters on preferential basis pursuant to warrant conversion
- Distinctive Numbers: 88652031 to 93652030
- ISIN: INE812G01025
- New shares rank pari-passu with existing equity shares
- Trading permitted from Friday, November 7, 2025
Regulatory Changes
No regulatory changes introduced by this circular.
Compliance Requirements
Trading members are informed to note the listing of these new securities for trading purposes starting November 7, 2025.
Important Dates
- Allotment Date: September 10, 2025
- Trading Commencement: November 7, 2025
- Lock-in Expiry: October 30, 2027
Impact Assessment
Market Impact: Minimal. The preferential allotment to promoters increases the paid-up capital but all shares are subject to a lock-in period of nearly 2 years, preventing immediate trading impact. The shares rank equally with existing shares, maintaining uniformity in shareholder rights.
Operational Impact: Standard listing notification requiring trading members to update their systems to reflect the increased share capital and lock-in restrictions for the specified distinctive number range.
Impact Justification
Routine preferential allotment to promoters with standard lock-in period. Limited market impact as shares are locked until 2027.